Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders.

Ford DC, Dahl NV, Strauss WE, Barish CF, Hetzel DJ, Bernard K, Li Z, Allen LF.

Clin Exp Gastroenterol. 2016 Jul 11;9:151-62. doi: 10.2147/CEG.S101473. eCollection 2016 Jul 11.

2.

Burden of Iron Deficiency Anemia in a Bariatric Surgery Population in the United States.

Knight T, D'Sylva L, Moore B, Barish CF.

J Manag Care Spec Pharm. 2015 Oct;21(10):946-54.

3.

Germline variants and advanced colorectal adenomas: adenoma prevention with celecoxib trial genome-wide association study.

Wang J, Carvajal-Carmona LG, Chu JH, Zauber AG; APC Trial Collaborators., Kubo M, Matsuda K, Dunlop M, Houlston RS, Sieber O, Lipton L, Gibbs P, Martin NG, Montgomery GW, Young J, Baird PN, Ratain MJ, Nakamura Y, Weiss ST, Tomlinson I, Bertagnolli MM.

Clin Cancer Res. 2013 Dec 1;19(23):6430-7. doi: 10.1158/1078-0432.CCR-13-0550. Epub 2013 Oct 1.

4.

Phase 2b, randomized, double-blind 12-week studies of TZP-102, a ghrelin receptor agonist for diabetic gastroparesis.

McCallum RW, Lembo A, Esfandyari T, Bhandari BR, Ejskjaer N, Cosentino C, Helton N, Mondou E, Quinn J, Rousseau F; TZP-102 Phase 2b Study Group..

Neurogastroenterol Motil. 2013 Nov;25(11):e705-17. doi: 10.1111/nmo.12184. Epub 2013 Jul 15.

5.

Nitroglycerin 0.4% ointment vs placebo in the treatment of pain resulting from chronic anal fissure: a randomized, double-blind, placebo-controlled study.

Berry SM, Barish CF, Bhandari R, Clark G, Collins GV, Howell J, Pappas JE, Riff DS, Safdi M, Yellowlees A.

BMC Gastroenterol. 2013 Jul 1;13:106. doi: 10.1186/1471-230X-13-106.

6.

Ustekinumab induction and maintenance therapy in refractory Crohn's disease.

Sandborn WJ, Gasink C, Gao LL, Blank MA, Johanns J, Guzzo C, Sands BE, Hanauer SB, Targan S, Rutgeerts P, Ghosh S, de Villiers WJ, Panaccione R, Greenberg G, Schreiber S, Lichtiger S, Feagan BG; CERTIFI Study Group..

N Engl J Med. 2012 Oct 18;367(16):1519-28. doi: 10.1056/NEJMoa1203572.

7.
8.

Statin use and colorectal adenoma risk: results from the adenoma prevention with celecoxib trial.

Bertagnolli MM, Hsu M, Hawk ET, Eagle CJ, Zauber AG; Adenoma Prevention with Celecoxib (APC) Study Investigators..

Cancer Prev Res (Phila). 2010 May;3(5):588-96. doi: 10.1158/1940-6207.CAPR-09-0271. Epub 2010 Apr 19.

9.

Comparison of preference and safety of powder and liquid lactulose in adult patients with chronic constipation.

Barish CF, Voss B, Kaelin B.

Clin Exp Gastroenterol. 2010;3:153-8. doi: 10.2147/CEG.S13568. Epub 2010 Oct 19.

10.

Efficacy and safety of lubiprostone in patients with chronic constipation.

Barish CF, Drossman D, Johanson JF, Ueno R.

Dig Dis Sci. 2010 Apr;55(4):1090-7. doi: 10.1007/s10620-009-1068-x. Epub 2009 Dec 11.

PMID:
20012484
11.

Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial.

Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Breazna A, Kim K, Tang J, Rosenstein RB, Umar A, Bagheri D, Collins NT, Burn J, Chung DC, Dewar T, Foley TR, Hoffman N, Macrae F, Pruitt RE, Saltzman JR, Salzberg B, Sylwestrowicz T, Hawk ET; Adenoma Prevention with Celecoxib Study Investigators..

Cancer Prev Res (Phila). 2009 Apr;2(4):310-21. doi: 10.1158/1940-6207.CAPR-08-0206. Epub 2009 Mar 31.

12.

Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximab.

Sands BE, Kozarek R, Spainhour J, Barish CF, Becker S, Goldberg L, Katz S, Goldblum R, Harrigan R, Hilton D, Hanauer SB.

Inflamm Bowel Dis. 2007 Jan;13(1):2-11.

PMID:
17206633
13.

A phase 1/2A trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohn's disease.

Burakoff R, Barish CF, Riff D, Pruitt R, Chey WY, Farraye FA, Shafran I, Katz S, Krone CL, Vander Vliet M, Stevens C, Sherman ML, Jacobson E, Bleday R.

Inflamm Bowel Dis. 2006 Jul;12(7):558-65.

PMID:
16804392
14.

Alicaforsen therapy in inflammatory bowel disease.

Barish CF.

Expert Opin Biol Ther. 2005 Oct;5(10):1387-91. Review.

PMID:
16197343
15.

Graded esophageal balloon distention. A new provocative test for noncardiac chest pain.

Barish CF, Castell DO, Richter JE.

Dig Dis Sci. 1986 Dec;31(12):1292-8.

PMID:
3803130
16.

Abnormal sensory perception in patients with esophageal chest pain.

Richter JE, Barish CF, Castell DO.

Gastroenterology. 1986 Oct;91(4):845-52.

PMID:
3743962
17.

Respiratory complications of gastroesophageal reflux.

Barish CF, Wu WC, Castell DO.

Arch Intern Med. 1985 Oct;145(10):1882-8. Review.

PMID:
2864025
18.

Complete distal renal tubular acidosis in systemic lupus: clinical and laboratory findings.

Caruana RJ, Barish CF, Buckalew VM Jr.

Am J Kidney Dis. 1985 Jul;6(1):59-63.

PMID:
4025329
19.

Venous thrombosis as a cause of superior vena cava syndrome. Rapid response to streptokinase.

Katz PO, Hackshaw BT, Barish CF, Powell BL.

Arch Intern Med. 1983 May;143(5):1050-2.

PMID:
6679218

Supplemental Content

Loading ...
Support Center